These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 35363818)
1. Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria. Iriemenam NC; Ige FA; Greby SM; Mpamugo A; Abubakar AG; Dawurung AB; Esiekpe MK; Thomas AN; Okoli MU; Awala SS; Ugboaja BN; Achugbu CC; Odoh I; Nwatu FD; Olaleye T; Akayi L; Akinmulero OO; Dattijo J; Onokevbagbe E; Okunoye O; Mba N; Agala NP; Uwandu M; Aniedobe M; Stafford KA; Abimiku A; Hamada Y; Swaminathan M; Okoye MI; Steinhardt LC; Audu R PLoS One; 2022; 17(4):e0266184. PubMed ID: 35363818 [TBL] [Abstract][Full Text] [Related]
2. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population. Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691 [TBL] [Abstract][Full Text] [Related]
3. Detection of IgG Antibodies to SARS-CoV-2 and Neutralizing Capabilities Using the Luminex King A; King G; Weiss C; Dunbar S; Das S Methods Mol Biol; 2022; 2511():257-271. PubMed ID: 35838966 [TBL] [Abstract][Full Text] [Related]
4. Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria. Iriemenam NC; Ige FA; Greby SM; Okunoye OO; Uwandu M; Aniedobe M; Nwaiwu SO; Mba N; Okoli M; William NE; Ehoche A; Mpamugo A; Mitchell A; Stafford KA; Thomas AN; Olaleye T; Akinmulero OO; Agala NP; Abubakar AG; Owens A; Gwyn SE; Rogier E; Udhayakumar V; Steinhardt LC; Martin DL; Okoye MI; Audu R J Clin Virol Plus; 2023 Feb; 3(1):100139. PubMed ID: 36683611 [TBL] [Abstract][Full Text] [Related]
5. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel. Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601 [TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative Immunoglobulin G Assays: The Value of Numeric Reporting. Forest SK; Orner EP; Goldstein DY; Wirchnianski AS; Bortz RH; Laudermilch E; Florez C; Malonis RJ; Georgiev GI; Vergnolle O; Lo Y; Campbell ST; Barnhill J; Cadoff EM; Lai JR; Chandran K; Weiss LM; Fox AS; Prystowsky MB; Wolgast LR Arch Pathol Lab Med; 2021 Aug; 145(8):929-936. PubMed ID: 33821952 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma. Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688 [TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers. Heffernan E; Kennedy L; Hannan MM; Ramlaul N; Denieffe S; Courtney G; Watt A; Hurley J; Lynch M; Fitzgibbon M Ann Clin Biochem; 2021 Sep; 58(5):496-504. PubMed ID: 33845592 [TBL] [Abstract][Full Text] [Related]
9. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations. Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay. Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Tancevski I; Weiss G; Anliker M; Griesmacher A; Hoermann G Clin Chem Lab Med; 2021 May; 59(6):1143-1154. PubMed ID: 33554557 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays. Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714 [TBL] [Abstract][Full Text] [Related]
12. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting. Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231 [TBL] [Abstract][Full Text] [Related]
13. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19. Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study. To KK; Cheng VC; Cai JP; Chan KH; Chen LL; Wong LH; Choi CY; Fong CH; Ng AC; Lu L; Luo CT; Situ J; Chung TW; Wong SC; Kwan GS; Sridhar S; Chan JF; Fan CY; Chuang VWM; Kok KH; Hung IF; Yuen KY Lancet Microbe; 2020 Jul; 1(3):e111-e118. PubMed ID: 33230504 [TBL] [Abstract][Full Text] [Related]